ChromaDex - 48 Year Dividend History | CDXC

Historical dividend payout and yield for ChromaDex (CDXC) since 1971. The current TTM dividend payout for ChromaDex (CDXC) as of April 24, 2019 is $0.00. The current dividend yield for ChromaDex as of April 24, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.244B $0.032B
ChromaDex Corporation and its subsidiaries supply phytochemical reference standards and reference materials, related contract services, and products for the dietary supplement, nutraceutical, food and beverage, functional food, pharmaceutical and cosmetic markets. ChromaDex's core business strategy is to use the intellectual property harnessed by its expertise in the area of natural products and in the creation of reference materials to the industry as the basis for providing new and alternative, `green`, mass marketable products to its customers. The Company's main priority is to create industry-accepted information, and to provide products and services to every layer of the functional food, pharmaceutical, personal care and dietary supplement markets. The company markets and sells its products in the United States and Canada. It offers its products through distributors in Europe, South America, Korea, India, Japan, Australia, New Zealand, China, Indonesia, Malaysia, Singapore, Thailand, and Mexico.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $109.824B 12.37
Gilead Sciences (GILD) United States $80.063B 10.19
Bio-Techne Corp (TECH) United States $7.211B 48.58